Physician profile
Arianne E Chavez
NPI 1972762565
$16,588.74
in general payments reported to CMS, 2019-2025
49 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 83% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,486 · 2020: $949 · 2021: $1,530 · 2022: $6,452 · 2023: $1,947 · 2024: $1,699 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,091 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,091.48 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $4,790.98 | 2020-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Abbvie INC. | $2,507.54 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $923.20 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Leo Pharma INC. | $723.16 | 2019-2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $673.95 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Genzyme Corporation | $631.61 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $594.83 | 2019-2025 | Libtayo, Dupixent |
| E.R. Squibb & Sons, L.L.C. | $563.24 | 2022-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $434.04 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $398.49 | 2019-2024 | Taltz, Ebglyss |
| Pfizer INC. | $398.12 | 2019-2024 | |
| Incyte Corporation | $397.38 | 2021-2025 | Opzelura |
| Organogenesis INC. | $349.12 | 2021-2025 | Puraply, Matrix, Puraply Wound Matrix |
| Novartis Pharmaceuticals Corporation | $251.54 | 2019-2023 | |
| Biofrontera INC. | $251.49 | 2020-2025 | Ameluz, Xepi, Bf-Rhodoled |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arianne Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.